Overview

PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

Status:
NOT_YET_RECRUITING
Trial end date:
2028-05-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to preliminarily observe the efficacy and safety of PCSK9 inhibitors in combination with standard advanced first-line regimens in the treatment of advanced colorectal cancer with pMMR/MSS.
Phase:
PHASE2
Details
Lead Sponsor:
Guangdong Provincial People's Hospital